Supernus Pharmaceuticals Inc (SUPN) — Strategic Asset Allocation Index
Supernus Pharmaceuticals Inc (SUPN) has a Strategic Asset Allocation Index of 0.0% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $1.04 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Supernus Pharmaceuticals Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Supernus Pharmaceuticals Inc Strategic Asset Allocation Index (2011–2024)
This chart shows how Supernus Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 14 annual periods from 2011 to 2024. As of December 2024, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $1.04 Billion USD. See Supernus Pharmaceuticals Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Supernus Pharmaceuticals Inc (2011–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Supernus Pharmaceuticals Inc from 2011 to 2024, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Supernus Pharmaceuticals Inc (SUPN) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $1.04 Billion | ▼ -1.8 pp |
| 2023 | 1.8% | $16.62 Million | $- | $16.62 Million | $921.52 Million | ▼ -13.8 pp |
| 2022 | 15.6% | $137.97 Million | $44.08 Million | $93.90 Million | $886.20 Million | ▼ -5.5 pp |
| 2021 | 21.0% | $171.49 Million | $52.32 Million | $119.17 Million | $815.85 Million | ▼ -31.1 pp |
| 2020 | 52.1% | $388.18 Million | $37.82 Million | $350.36 Million | $744.86 Million | ▼ -50.1 pp |
| 2019 | 102.3% | $608.84 Million | $17.07 Million | $591.77 Million | $595.43 Million | ▲ +8.9 pp |
| 2018 | 93.3% | $422.89 Million | $4.09 Million | $418.80 Million | $453.02 Million | ▲ +41.5 pp |
| 2017 | 51.9% | $138.76 Million | $5.12 Million | $133.64 Million | $267.48 Million | ▲ +10.3 pp |
| 2016 | 41.6% | $79.75 Million | $4.34 Million | $75.41 Million | $191.75 Million | ▼ -7.9 pp |
| 2015 | 49.5% | $58.88 Million | $3.87 Million | $55.01 Million | $118.88 Million | ▲ +18.3 pp |
| 2014 | 31.2% | $22.26 Million | $2.45 Million | $19.82 Million | $71.35 Million | ▼ -2.6 pp |
| 2013 | 33.8% | $11.31 Million | $2.55 Million | $8.76 Million | $33.46 Million | ▲ +31.3 pp |
| 2012 | 2.5% | $1.42 Million | $1.42 Million | $- | $57.57 Million | ▼ -11.4 pp |
| 2011 | 13.9% | $1.31 Million | $1.31 Million | $- | $9.44 Million | — |